At the BIO CEO & Investor Digital Conference, taking place February 16-18, 2021, you will hear key biotech and pharma leaders discuss the most pertinent industry trends, the market outlook, and best practices for executive leadership.
#BIOCEO21 topics include:
- Progress in Drugging the Undruggable Cancer Targets
- SPACs: Criteria for Successful Launches
- Reverse Trend: China’s Shift to a Center for Innovation
- Deal Making in the Next Decade: Lessons Learned and Planning for Tomorrow
- CRISPR’s Progress for Patients: Clinical Development of Therapies
- Policy Scenarios on Investor’s Reactions to Reference Pricing Models
- Policy Outlook: Reviewing the Pathway for Advancing Biopharma Goals in the Congress and White House
- Turning RNA Research into Medicines
- Market Outlook: Breaking Records or Expecting an Adjustment